ACI Learning Partners with OMREN to Deliver Hands-On Cybersecurity and IT Skill Labs Across Oman
Global leader in IT and cybersecurity training expands into Southwest Asia with a two-year tender, bringing hands-on Skill Labs to universities to strengthen foundational... Read more.
Ubiqconn Technology and RuggON Unveil Next-Gen Mission Ecosystem at TADTE 2025
New Ground Control Station and Integrated Satellite Solutions Empower Industries to Improve Operational Efficiency and Safety TAIPEI, Sept. 16, 2025 /PRNewswire/... Read more.
StubHub Announces Pricing of Initial Public Offering
NEW YORK, Sept. 16, 2025 /PRNewswire/ — StubHub Holdings, Inc. (“StubHub”), a leading global secondary ticketing marketplace for live events, today... Read more.
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
– ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment.... Read more.
G-P Named an Industry Leader in NelsonHall’s Global Employer of Record (EOR) Market Analysis for Fifth Consecutive Report
The NelsonHall 2025 Global EOR Services NEAT Evaluation highlights G-P as an industry leader in technology innovation and its commitment to offering comprehensive,... Read more.
LANZAJET – AN EARLY MOVER IN AUSTRALIA – APPLAUDS THE AUSTRALIAN GOVERNMENT’S LEADERSHIP AND GAME-CHANGING $1.1B (AUD) INVESTMENT TO ADVANCE SUSTAINABLE FUELS
LanzaJet’s Alcohol-to-Jet technology for sustainable fuel production is key to enabling the development of the industry in Australia while strengthening the... Read more.
Lilly’s oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine
The investigational once-daily oral pill led to an average weight loss of 27.3 lbs (12.4%) at the highest dose at week 72 in the Phase 3 study Orforglipron demonstrated... Read more.
KAT6 Inhibitors Market Poised for Significant Growth During the Forecast Period (2025-2040) | DelveInsight
The outlook for the KAT6 inhibitors market is strengthening as interest in epigenetic targets grows and KAT6A/B gain recognition as critical drivers of cancer progression.... Read more.
Aquatech Acquires Koch’s Direct Lithium Extraction Business, Integrating Li-Pro™ DLE into the PEARL™ Technology Platform
CANONSBURG, Pa., Sept. 16, 2025 /PRNewswire/ — Aquatech has acquired Koch Technology Solutions’ (KTS) direct lithium extraction (DLE) business, integrating... Read more.
Select GCR: The Changes in Gov Q4 Spending Create Optimism and Consistency for 2026??
TAMPA BAY, Fla., Sept. 16, 2025 /PRNewswire/ — For decades, small and mid-sized businesses have watched the federal budget follow the same exhausting cycle:... Read more.